Ticker: ACRS

Company: Aclaris Therapeutics, Inc.

Person: Kevin Balthaser, officer

Transaction date: Feb. 3, 2026

Reporting date: Feb. 5, 2026

Average share price: -1.4366994093477146

Sold 15576.0 shares for 22378.03